HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: gut.2005.068809v1 55/1/47    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ardizzone, S Articles by Bianchi Porro, G Search for Related Content PubMed PubMed Citation Articles by Ardizzone, S Articles by Bianchi Porro, G Topic Collections Relevant Articles

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis

¹ Chair of Gastroenterology, "L Sacco" University Hospital, Milan, Italy
² Epidemiology Unit, Local Health Authority, Milan, Italy

Correspondence to:
Correspondence to:
Dr S Ardizzone
Cattedra di Gastroenterologia, Azienda Ospedaliera "L Sacco", Polo Universitario, Via G.B. Grassi, 74, 20157 Milano, Italy; samari1{at}tin.it

Background and aim: There are limited evidence based data concerning the use of azathioprine in ulcerative colitis. We aimed to compare the efficacy of azathioprine and oral 5-aminosalicylic acid in inducing remission of steroid dependent ulcerative colitis.

Methods: Seventy two patients with steroid dependent ulcerative colitis were admitted to this investigator-blind study. Steroid dependence was defined as a requirement for steroid therapy 10 mg/day during the preceding six months, with at least two attempts to discontinue the medication. The disease had to be clinically and endoscopically active at study entry, and all patients were taking systemic prednisolone (40 mg/day). Patients were randomised to receive azathioprine 2 mg/kg/day or oral 5-aminosalicylic acid 3.2 g/day, for a six month follow up period. The outcome of the treatment was defined as (1) success, indicating induction of clinical and endoscopic remission and steroid discontinuation, or (2) failure, indicating the absence of clinical and endoscopic remission and therefore the need for at least one further cycle of systemic steroids to control symptoms, apart from the initial one, or colectomy.

Results: Significantly more patients in the azathioprine than in the 5-aminosalicylic acid group had clinical and endoscopic remission, and discontinued steroid therapy, both in the intention to treat (azathioprine v 5-aminosalicylic acid: 19/36 patients (53%) v 7/36 (21%); odds ratio (OR) 4.78 (95% confidence interval (CI) 1.57–14.5)) and per protocol (azathioprine v 5-aminosalicylic acid: 19/33 patients (58%) v 7/34 (21%); OR 5.26 (95% CI 1.59–18.1)) analysis.

Conclusions: Azathioprine is significantly more effective than 5-aminosalicylic acid in inducing clinical and endoscopic remission and avoiding steroid requirement in the treatment of steroid dependent ulcerative colitis.

Abbreviations: AZA, azathioprine; 5-ASA, 5-aminosalicylic acid; UC, ulcerative colitis; 6-MP, 6-mercaptopurine; PGA, physician global assessment; OR, odds ratio

Keywords: steroid dependent ulcerative colitis; azathioprine; 5-aminosalicylic acid

Relevant Articles

Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn’s disease

H Herfarth, C Tjaden, M Lukas, F Obermeier, K Dilger, R Müller, J Schölmerich A Z T-1 Study Group
Gut 2006 55: 1525-1526. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				W. Stremmel, R. Ehehalt, F. Autschbach, and M. Karner Phosphatidylcholine for Steroid-Refractory Chronic Ulcerative Colitis: A Randomized Trial Ann Intern Med, November 6, 2007; 147(9): 603 - 610. [Abstract] [Full Text] [PDF]

				S. De Iudicibus, G. Stocco, S. Martelossi, I. Drigo, S. Norbedo, P. Lionetti, E. Pozzi, A. Barabino, G. Decorti, F. Bartoli, et al. Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease Gut, September 1, 2007; 56(9): 1319 - 1320. [Full Text] [PDF]

				K R Herrlinger, K Fellermann, and E F Stange Tacrolimus--finally! Gut, September 1, 2006; 55(9): 1224 - 1225. [Full Text] [PDF]

				B E Sands Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories? Gut, April 1, 2006; 55(4): 437 - 441. [Abstract] [Full Text] [PDF]

				S Ghosh, R Chaudhary, M Carpani, and R J Playford Is thiopurine therapy in ulcerative colitis as effective as in Crohn's disease? Gut, January 1, 2006; 55(1): 6 - 8. [Full Text] [PDF]

eLetters: